Tolerability of MK0524A Versus Niacin Extended-Release (0524A-054)

Clinical trial NCT00378833 · COMPLETED

Trial details

NCT number: NCT00378833
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hypercholesterolemia Hyperlipidemia

Start date: 2006-07-01
Primary completion: 2007-03-01
Enrollment: 1300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.